Sarepta Therapeutics
Biopharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Sarepta Therapeutics?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals,[1] shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively.[2] As of 2023, the company has four approved drugs (see the Products section below).
This article needs to be updated. (December 2016) |
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
Founded | 1980; 44 years ago (1980) |
Headquarters | Cambridge, Massachusetts, U.S. |
Key people | Douglas S. Ingram (CEO & President) |
Revenue | US$1.243 billion (2023) |
Number of employees | 1,314 (December 2023) |
Website | www |
Close